-
Published14/10/2025
-
Today07/11/2025
-
Deadline14/11/2025
Utilities
- indicates text translated automatically in your browsing language
Autologous cell therapy medicinal product - idekabtagen vikleucel - 2025 Text automatically translated in your browsing language Automatically translated
The subject of the public contract is the supply of a medicinal product intended for the treatment of malignant blood diseases in a total estimated volume of 32 individual doses of the medicinal product. The product is intended for the provision of health care at the health care facility of the University Hospital Pilsen. Deliveries of the subject of performance will be carried out on the basis of the results of the completed procurement procedure for a period of four years from the signing of the purchase contract. Text automatically translated in your browsing language Automatically translated
https://tenderarena.cz/profil/fnplzen
https://tenderarena.cz/profil/fnplzen
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.